Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

274 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Results of a European Organization for Research and Treatment of Cancer/Early Clinical Studies Group phase II trial of first-line irinotecan in patients with advanced or recurrent squamous cell carcinoma of the cervix.
Lhommé C, Fumoleau P, Fargeot P, Krakowski Y, Dieras V, Chauvergne J, Vennin P, Rebattu P, Roche H, Misset JL, Lentz MA, Van Glabbeke M, Matthieu-Boué A, Mignard D, Chevallier B. Lhommé C, et al. J Clin Oncol. 1999 Oct;17(10):3136-42. doi: 10.1200/JCO.1999.17.10.3136. J Clin Oncol. 1999. PMID: 10506610 Clinical Trial.
High-dose platinum versus standard dose in advanced ovarian carcinoma: a randomized trial from the Gynecologic Cooperative Group of the French Comprehensive Cancer Centers (FNCLCC).
Joly F, Héron JF, Kerbrat P, Chauvergne J, Rios M, Mayer F, Chinet-Charrot P, Goupil A, Lebrun-Jezekova D, Vennin D, Lhommé C, Macé-Lesec'h J, Crouet H. Joly F, et al. Among authors: lhomme c. Gynecol Oncol. 2000 Sep;78(3 Pt 1):361-8. doi: 10.1006/gyno.2000.5923. Gynecol Oncol. 2000. PMID: 10985895 Clinical Trial.
Phase II study of pirarubicin (THP) in patients with cervical, endometrial and ovarian cancer: study of the Clinical Screening Group of the European Organization for Research and Treatment of Cancer (EORTC).
Chauvergne J, Fumoleau P, Cappelaere P, Metz R, Armand JP, Chevallier B, Kerbrat P, de Forni M, Lhommé C, Roche H, et al. Chauvergne J, et al. Among authors: lhomme c. Eur J Cancer. 1993;29A(3):350-4. doi: 10.1016/0959-8049(93)90384-r. Eur J Cancer. 1993. PMID: 8398333 Clinical Trial.
Carcinoma of the cervix.
Resbeut M, Fondrinier E, Fervers B, Haie-Meder C, Bataillard A, Lhommé C, Asselain B, Basuyau JP, Brémond A, Castaigne D, Dubois JB, Houvenaeghel G, Lartigau E, Leblanc E, Sastre-Garaud X, Ternier F, Guastalla JP, Chauvergne J; French National Federation of Cancer (FNCLCC). Resbeut M, et al. Among authors: lhomme c. Br J Cancer. 2001 May;84 Suppl 2(Suppl 2):24-30. doi: 10.1054/bjoc.2001.1759. Br J Cancer. 2001. PMID: 11355965 Free PMC article. No abstract available.
274 results